StockMarketWire.com - JP Morgan Cazenove today initiates coverage of GlaxoSmithKline PLC [LON:GSK] with a neutral investment rating and price target of 1700p.

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk